Senator Elizabeth Warren of Massachusetts, a Democrat, has recently raised concerns about the impact of the Affordable Care Act (ACA), commonly known as ObamaCare, on healthcare costs and industry practices. According to an editorial by the Wall Street Journal, Warren, who has been a supporter of the ACA, is now scrutinizing the healthcare law for contributing to market consolidation and price hikes.
In a bipartisan effort with Senator Mike Braun, a Republican from Indiana, Warren has addressed a letter to the inspector general of the Department of Health and Human Services. The letter seeks an investigation into whether vertically integrated healthcare companies are inflating prescription drug prices and circumventing federal regulations designed to ensure fair pricing.
The senators highlighted that some of the nation’s largest health insurers might be skirting the medical loss ratio (MLR) requirements of ObamaCare. This rule was intended to guarantee that a significant portion of premium revenues is spent on medical care rather than administrative costs or profits.
Warren pointed out that by controlling multiple aspects of the healthcare supply chain — from insurance to pharmacies and physician practices — conglomerates are able to manipulate financial flows to appear compliant with MLR regulations while retaining increased profits. This practice particularly impacts consumers who rely on specialty pharmacies and are not benefiting from the lower costs of generic drugs as intended.
The Wall Street Journal editorial board elaborated that the MLR, although aimed at protecting patients, has inadvertently driven insurers to acquire other healthcare entities such as pharmacy benefit managers (PBMs) and pharmacies. This has resulted in less transparent healthcare spending, as insurers can reallocate profits within their affiliates by adjusting reimbursements.
Despite voting against ObamaCare repeal efforts and advocating for a “Medicare for All” system during her 2020 presidential campaign, Warren’s recent actions suggest a shift towards addressing the unintended consequences of the ACA.
At the time of reporting, neither Senator Warren’s office nor the Department of Health and Human Services had responded to media inquiries for further comment.